Charalampos Floudas, MD, DMSc, MS

Charalampos S. Floudas, MD, DMSc, MS

  • Center for Cancer Research
  • National Cancer Institute
Center for Immuno-Oncology


Dr. Floudas is a Head and Neck Cancer (HNC) Medical Oncologist that designs and conducts early-phase clinical trials. Dr. Floudas is also applying artificial intelligence and data science to multi-layered omics data for biomarker discovery.

Areas of Expertise

Head and Neck Cancer; Clinical trials; Cancer immunotherapy; Biomarker discovery; Clinical Computational Oncology; Artificial Intelligence

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.


Selected Key Publications

A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer

Floudas CS, Brar G, Mabry-Hrones D, Duffy AG, Wood B, Levy E, Krishnasamy V, Fioravanti S, Bonilla CM, Walker M, Morelli MP, Kleiner DE, Steinberg SM, Figg WD, Greten TF, Xie C.
Clin Colorectal Cancer. Epub ahead of print, 2019. [ Journal Article ]

Immunotherapy: Current Status and Future Perspectives

Floudas CS, Brar G, Greten TF.
Dig Dis Sci. 64(4): 1030–1040, 2019. [ Journal Article ]

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy

Kumar V, Chaudhary N, Garg M, Floudas CS, Soni P, Chandra A.
Front Pharmacol. 8: 49, 2017. [ Journal Article ]

Vemurafenib in leptomeningeal carcinomatosis from melanoma: a case report of near-complete response and prolonged survival

Floudas CS, Chandra AB, Xu Y.
Melanoma Res. 26(3): 312-5, 2016. [ Journal Article ]

Identifying genetic interactions associated with late-onset Alzheimer's disease

Floudas CS, Um N, Kamboh MI, Barmada MM, Visweswaran S.
BioData Min. 7(1): 35, 2014. [ Journal Article ]